Pacesa argues that closed-source models won't significantly outperform open-source tools because most rely on the same public PDB data. The true competitive advantage lies not in tweaking algorithms but in generating massive, proprietary, high-quality experimental datasets that can train genuinely superior models.

Unlike consumer AI trained on public internet data, industrial AI requires vast, proprietary datasets from the physical world (e.g., sensor readings from a submarine hull). Gecko Robotics is building this data corpus via its robots, creating an advantage that's difficult to replicate.

Since LLMs are commodities, sustainable competitive advantage in AI comes from leveraging proprietary data and unique business processes that competitors cannot replicate. Companies must focus on building AI that understands their specific "secret sauce."

The future of valuable AI lies not in models trained on the abundant public internet, but in those built on scarce, proprietary data. For fields like robotics and biology, this data doesn't exist to be scraped; it must be actively created, making the data generation process itself the key competitive moat.

As AI application layers become easier to clone, the sustainable competitive advantage is moving down the tech stack. Companies with unique, last-mile user interaction data can build proprietary models that are cheaper and better, creating a data flywheel and a moat that is difficult for competitors to replicate.

The key advantage for AI biotech isn't the model itself, but generating massive, proprietary datasets ("science tokens") via automated labs. This novel data, which doesn't exist publicly, is crucial for training superior models and achieving true scientific intelligence.

Algorithmic improvements alone are not enough for a new AI lab to challenge incumbents, who are also researching next-gen architectures. The only viable path is to focus on domains where proprietary data can be generated and is unavailable to the big labs, such as robotics or specialized life sciences.

The long-theorized "data network effect" is now a powerful reality in the age of AI. Access to a proprietary and, most importantly, *live* data stream creates a significant moat. A commodity AI model trained on this unique, dynamic data can outperform a state-of-the-art model that lacks it.

Companies create defensibility by generating unique, non-public data through their operations (e.g., legal case outcomes). This proprietary data improves their own models, creating a feedback loop and a compounding advantage that large, generalist labs like OpenAI cannot replicate.